|Articles|June 4, 2019

Lower Humidity Linked to More Severe Flu Illness

Author(s)Einav Keet

A research team led by Yale University scientists report that breathing dry air lowers defenses against influenza virus infection.

Can using a humidifier help prevent you from getting the flu? Maybe so, according to new study on the link between low humidity and influenza virus severity.

Studies have shown there is a link between climate and influenza, and that decreases in humidity levels common in winter months can be a driver during flu season. In a study published online in the Proceedings of the National Academy of Sciences (PNAS), investigators cited previous findings that a drop in absolute humidity, which is dependent on relative humidity and temperature, correlates most closely with the rise in seasonal influenza-related deaths. In this study the investigators aimed to look further into the effects of low ambient humidity on enhancing influenza virus transmission.

“Before our study, while it was known that winter climate is associated with the transmission of flu, the impact of humidity on how the host responds to flu once we are infected by the virus was unknown,” said study co-author Eriko Kudo, who is a post-doctoral associate in the Department of Immunobiology, in an interview with Contagion®.

The authors note that the respiratory mucosal barrier provides the first line of defense against influenza and if the virus breaches this barrier it triggers innate immune defense mechanisms. Using Mx1 congenic mice genetically modified to have human resistance to viral infection, the study team examined the impacts of relative humidity on the mice’s response to influenza A virus infection and disease outcomes. The mice were kept in chambers at either a low relative humidity of 10-20% or at higher relative humidity of 50%.

The study team found that the mice kept in low humidity conditions had impaired defenses and were more susceptible overall to influenza illness and experienced more severe flu symptoms than mice kept in higher relative humidity. Lower levels of relative humidity impaired mucociliary clearance and tissue repair and blocked the induction of the interferon-stimulated genes known to restrict influenza A viruses, leading to higher viral burden. In addition, dry air exposure made mice more susceptible to disease mediated by inflammasome caspases.

“It’s well known that where humidity drops, a spike in flu incidence and mortality occurs,” said, Akiko Iwasaki, PhD, the Waldemar Von Zedtwitz Professor of Immunobiology at Yale University and study lead author in a recent statement. “If our findings in mice hold up in humans, our study provides a possible mechanism underlying this seasonal nature of flu disease.”

In their paper the investigators note that though host defenses against influenza are not impacted by humidity in all situations, influenza virus can thrive in the warm, wet conditions of tropical and subtropical settings.

“Future studies will be required to understand why certain regions of the world may be affected differently by humidity and temperature,” write the authors, adding that the use of humidifiers in the winter months and flu season may have benefits. “Our study suggests that increasing ambient humidity may be a viable strategy to reduce disease symptoms and to promote more rapid recovery in influenza-infected individuals.”


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.